Your browser doesn't support javascript.
loading
A randomized phase II study of capecitabine-based chemoradiation with or without bevacizumab in resectable locally advanced rectal cancer: clinical and biological features.
Salazar, Ramon; Capdevila, Jaume; Laquente, Berta; Manzano, Jose Luis; Pericay, Carles; Villacampa, Mercedes Martínez; López, Carlos; Losa, Ferran; Safont, Maria Jose; Gómez, Auxiliadora; Alonso, Vicente; Escudero, Pilar; Gallego, Javier; Sastre, Javier; Grávalos, Cristina; Biondo, Sebastiano; Palacios, Amalia; Aranda, Enrique.
Afiliação
  • Salazar R; Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain. ramonsalazar@iconcologia.net.
  • Capdevila J; Medical Oncology, Hospital Universitari Vall D'Hebrón, Barcelona, Spain. jacapdevila@vhebron.net.
  • Laquente B; Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain. blaquente@iconcologia.net.
  • Manzano JL; Medical Oncology, Hospital Universitari German Trias I Pujol, Barcelona, Spain. jmanzano@iconcologia.net.
  • Pericay C; Medical Oncology, Complejo Sanitario Parc Taulí, Barcelona, Spain. cpericay@gmail.com.
  • Villacampa MM; Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain. mmvillacampa@iconcologia.net.
  • López C; Medical Oncology, Hospital Universitario Marqués de Valdecilla, Santander, Spain. clopez@humv.es.
  • Losa F; Medical Oncology, Hospital General de L'Hospitalet, Barcelona, Spain. ferran.losa@sanitatintegral.org.
  • Safont MJ; Medical Oncology, Hospital General Universitario de Valencia, Valencia, Spain. mjsafont@yahoo.es.
  • Gómez A; Medical Oncology, Reina Sofía Hospital, University of Córdoba, Maimonides Institute of Biomedical Research (IMIBIC); Spanish Cancer Network (RTICC), Instituto de Salud Carlos III, Córdoba, Spain. magespanya@hotmail.com.
  • Alonso V; Medical Oncology, Hospital Universitario Miguel Servet, Zaragoza, Spain. valonsoo@salud.aragon.es.
  • Escudero P; Medical Oncology, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain. pilaresc@gmail.com.
  • Gallego J; Medical Oncology, Hospital General U. de Elche, Alicante, Spain. j.gallegoplazas@gmail.com.
  • Sastre J; Medical Oncology, Hospital Clínico Universitario San Carlos, Madrid, Spain. jsastrev@salud.madrid.org.
  • Grávalos C; Medical Oncology, Hospital Doce de Octubre, Madrid, Spain. cgravalos@telefonica.net.
  • Biondo S; General and Digestive Surgery Hospital Universitario de Bellvitge, Barcelona, Spain. sbiondo@bellvitgehospital.cat.
  • Palacios A; Radiation Oncology, Hospital Universitario Reina Sofía, Córdoba, Spain. amalia.palacios.sspa@juntadeandalucia.es.
  • Aranda E; Medical Oncology, Reina Sofía Hospital, University of Córdoba, Maimonides Institute of Biomedical Research (IMIBIC); Spanish Cancer Network (RTICC), Instituto de Salud Carlos III, Córdoba, Spain. earandaa@seom.org.
BMC Cancer ; 15: 60, 2015 Feb 26.
Article em En | MEDLINE | ID: mdl-25886378
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Eixos temáticos: Pesquisa_clinica Base de dados: MEDLINE Assunto principal: Neoplasias Retais / Quimiorradioterapia Adjuvante / Capecitabina / Bevacizumab Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Eixos temáticos: Pesquisa_clinica Base de dados: MEDLINE Assunto principal: Neoplasias Retais / Quimiorradioterapia Adjuvante / Capecitabina / Bevacizumab Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article